Safe 1986
Safe 1986
REVIEWS Further
Quick links to online content
MECHANISM OF ACTION OF
POL YCHLORINATED
DIBENZO-P-DIOXINS AND
DIBENZOFURANS
S. H. Safe
Department of Physiology and Pharmacology, College of Veterinary Medicine, Texas
A&M University, College Station, Texas 77843
INTRODUCTION
371
0362-1642/86/0415-0371$02.00
372 SAFE
1 940s and that "this historical increase is similar to trends for the production,
use, and disposal of chlorinated organic compounds" (17, 1 8).
Human exposure to PCDDs and PCDFs has occurred via three major path
ways: occupational, accidental, and environmental. Industrial workers en
gaged in the manufacture or use of polychlorinated biphenyls, chlorinated
phenols, and their derived products are exposed to PCDDs and/or PCDFs in
combination with their associated major commercial product ( 1 9-21 ) . Acci
dents in which PCDDs have been released into the workplace or into the
environment (e. g. the Seveso accident in Italy) have also resulted in human
exposure to mixtures of the industrial chemicals and their PCDD/PCDF toxic
contaminants (22-24). The Yusho poisoning in Japan and Taiwan involved the
exposure of several thousand individuals to PCBs and their PCDF contaminants
(5 , 6, 25-27). The uptake of environmental residues of PCDDs and PCDFs into
higher trophic levels of the food chain is only now being investigated, and trace
levels (parts per trillion) have been detected in fish, wildlife, and human tissues
( 1 9 , 28-32). In common with accidental and industrial exposures to PCDDs
and PCDFs, exposure levels to these toxins represent only a small fraction of
the total bioavailable lipophilic environmental pollutants. 2 , 3,7 ,8-
Tetrachlorodibenzo-p-dioxin (TCDD) is the major by-product formed from
2,4,5-trichlorophenol and its derived products; this highly toxic compound has
been the focus of most biologic and toxic studies on the PCDDs. However, all
other human and environmental exposures to PCDDs and PCDFs involve a
complex mixture of isomers and congeners in combination with other chem
icals.
The scientific, regulatory, and media attention focused on PCDDs, PCDFs,
and particularly 2,3,7 ,8-TCDD has continued unabated; moreover, with the
recent identification of trace levels of these toxins in human tissue, domestic
animals, the environment, and toxic chemical waste dumpsites, the scientific
and societal concern about this class of compounds will no doubt continue. It is
apparent from the scientific literature that one member of this class of com
pounds, namely 2,3,7 ,8-TCDD , ranks with benzo[a]pyrene as one of the most
thoroughly studied toxins. Unfortunately, the biologic and toxic effects of the
remaining 74 PCDD and 1 35 PCDF congeners have not been thoroughly
PCDDs AND PCDFs-SARs 373
developed for both PCDD and PCDF congeners, and (d) discusses the few
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
Several review articles (33-45) have summarized the toxic and biologic effects
elicited by PCDDs, PCDFs, and related toxic halogenated aryl hydrocarbons.
The toxic effects resulting from exposure to this group of chemicals are
dependent on a number of factors which include the dose of the toxin, and the
age, strain, species, and sex of the animals used. The complete spectrum of
toxicity is not usually observed in any single animal species; however, the
limited data available indicate that the toxic PCDDs, PCDFs, and related
compounds elicit the same qualitative pattern of responses within each species.
The differences in species susceptibility to this group of chemicals are illus
trated by the LDso values for 2,3,7,8-TCDD, which vary over 5000-fold (33,
34) from the highly sensitive guinea pig to the resistant hamster [LDsos (j.Lg/kg);
guinea pig (0.6--2.0), rat (22-45), chicken (25-50), monkey (70), rabbit (115),
dog ( l 00-200), mouse (114-284), bullfrog (> 1000), hamster (1157-5051)].
The quantitative differences in the toxicity of PCDF congeners have recently
been demonstrated (47) for a series of ten congeners (see structure-activity
section, below). The 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) EDso val
ues for thymic atrophy and body weight loss in the rat were 0.21 and 1.04
j.Lmol/kg; the 1,2,4,7,8-PeCDF isomer elicited the same toxic effects, but the
EDso values were 220 and 47 times higher, respectively (47). The toxic
responses observed in several animal species by PCDDs and PCDFs include
dermal toxicity, teratogenicity, reproductive problems, body weight loss,
hepatotoxicity, gastric lesions, lymphoid involution, immunotoxicity, and
carcinogenicity. The two most characteristic toxic effects observed in all
laboratory animals are lymphoid involution and/or immunotoxicity and body
weight loss. Chloracne and related dermal lesions are the most frequently noted
signs of PCDD and PCDF toxicosis in humans; dermal lesions are also observed
in rhesus monkeys, hairless mice, and rabbits that have been exposed to this
group of toxins. In contrast, rats, most strains of mice, guinea pigs, and
hamsters do not develop chloracne and related dermal toxic lesions after
374 SAFE
r:'Y
Figure 1 Structure of the polychlorinated dibenzofurans and dibenzo-p-dioxins.
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
exposure to 2,3,7,8-TCDD. Poland & Knutson (38) have noted that many of
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
(43). More recent studies (7 1 , 72) have demonstrated that thyroid hormones
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
from liver (5. 4 0.3 fmoVmg), lung (7.4 0.3 fmol/mg), and kidney (4.7
0.1 fmol/mg). The appearance of hepatic nuclear radiolabeled ligand-receptor
protein complexes and the elimination of this radioactivity by preinjection with
a large excess of unlabeled 2,3,7,8-TCDD has been reported by several groups
(89, 91, 96, 99, 102, 106); however, Mason & Okey (96) demonstrated that
lung, liver, and kidney nuclear Ah receptor levels were higher in the responsive
C57BLl6J mice than in the nonresponsive DBA/2J strain. This observation is
consistent with the fact that 2,3,7 ,8-TCDD and other toxic halogenated aryl
hydrocarbons elicit biologic and toxic responses in both strains of mice but at
different dose levels. Unfortunately there are insufficient data available to
correlate tissue/organ receptor levels with the magnitude of specific responses
in these target sites.
The criteria for receptor response specificity are supported by numerous
studies with genetically inbred responsive and nonresponsive strains of mice
and with some mammalian cells in culture. For example, there is an excellent
rank order correlation between the maximum AHH inducibility in several
inbred strains of mice and FI hybrids and the number of Ah receptor molecules
per liver cell (109). Nebert and co-workers have also shown a linear correlation
(r:= 0.99) between the amount of 2,3,7,8-TCDD-receptor complex appearing
in hepatic nuclei of C57BL/6 and DBAI2 mice and the percentage of maximally
induced cytochrome PI-450 mRNA (104). Hudson and co-workers have
demonstrated that for several human squamous cell carcinoma lines, the rela
tive amount of receptor measured in each cell line correlated well with the
7-ethoxycoumarin O-deethylase inducibility in these cells by 2,3,7,8-TCDD
(110).
These data that support the receptor-mediated response specificity are in
contrast to data in several other studies with animals and cell cultures. Hepatic
2,3,7,8-TCDD receptor levels in guinea pigs, rats, mice, hamsters, and nonhu
man primates vary less than tenfold (10-100 fmoVmg cytosolic protein) and
exhibit comparable KD values for [3H]-2,3,7,8-TCDD binding (93); these
levels show no correlation between their maximal hepatic AHH inducibility or
susceptibility to the toxic effects of 2,3,7,8-TCDD and related halogenated aryl
hydrocarbons (93, 97, 108). For several mammalian cells in culture there is no
correlation between receptor levels and their AHH inducibility (98, 99, 111-
113). Recent studies by Whitlock and co-workers indicate "that transcription of
378 SAFE
the cytochrome PI-450 gene is under both positive and negative control by at
least two trans-acting regulatory factors" (113). The factors that control
cytochrome P 1-450 in variant mouse heptoma cells may also play a role in some
animal species and requires further investigation. It is apparent that response
specificity to Ah receptor ligands is a highly complex process that depends not
only on receptor levels but also on many other factors, an observation not
unique to the Ah receptor protein (113, 114).
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
Structure-Activity Relationships
EFFECTS Poland, Glover & Kende first reported the relative binding affinities
of 23 halogenated dibenzo-p-dioxins and dibenzofurans using the dextran
charcoal receptor assay and [3H]-2,3,7,8-TCDD as the competing radioligand
(85). This study included 10 PCDD congeners and 7 PCDF congeners that
differed only with respect to their degree of chlorination and substitution
pattern. Table 1 summarizes results from a more recent study of the effects of
structure on the receptor binding affinities of 14 PCDDs and 14 PCDFs using rat
hepatic cytosol and the sucrose density gradient assay procedure (47, 51; G.
Mason, J. Pikorska-Pilszczynska, B. Keys & S. Safe, unpublished results).
2,3,7,8-TCDD and 1,2,3,7,8-pentachlorodibenzo-p-dioxin were the most avid
PCDD competitive binding ligands for displacement of [3H]-2,3,7,8-TCDD
from the receptor protein, and their ECso values were 1.0 x 10-8 and 7.9 x
10-8 M, respectively. Inspection of these data clearly demonstrated the im
portance of the lateral CI substituents in facilitating the interaction between the
PCDD ligands and the cytosolic receptor protein. The relative receptor binding
EC50 values for a series of tetrachloro isomers were 2,3,7,8- > 2,3,6,7- >
1,3,7,8- > 1,2,3,4-, in the order of decreasing number of lateral substituents.
The fivefold difference in the receptor binding activities of the 2,3,6,7- and
1,3,7,8-TCDD isomers illustrates a more subtle structural feature that affects
binding. The increased affinity of the former compound must be due to the
receptor binding site preference for a vicinal 6,7- (or, 1,2) group over a meta
1 ,3-dichloro functionality. The data also illustrate that the degree of chlorina
tion of non-lateral sites is an important structural determinant for interaction
with the receptor protein. The 2,3,7,8-tetra-, 1,2,3,7,8-penta-, 1,2,3,4,7,8-
hexa-, and 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxins all contain four later
al CI substituents; however, there is a marked decrease in their receptor binding
avidities with increasing CI substitution at the nonlateral 1, 4, 6, and 9
positions. The stepwise addition of CI groups at 1, 4, 6, and 9 would result in
several structural changes in the more highly chlorinated PCDDs including
increased molecular size and volume, increased lipophilicity, a possible de
crease in PCDD coplanarity associated with steric crowding, and decreased
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
Table 1 The effects of structure on the rat hepatic cytosolic receptor binding affinities and AHHfEROD induction potencies of PCDDs and PCDFs
Receptor Receptor
PCDD Binding AHH EROD PCDF Binding AHH EROD
2,3,7,8- 1.0 x 10-8 7.2 X 10-11 1.9 X 10-10 2,3,4,7,8- 1.5 x 10-8 2.6 X 10-10 1.3 X 10-10
1,2,3,7,8- 7.9 x 10-8 1.1 X 10-8 1.7 X 10-8 2,3,4,7- 2.5 x 10-8 1.8 X 10-8 1.5 X 10-8
2,3,6,7- 1.6 x 10-7 6.1 X 10-8 1 . 1 X 10-8 2,3,7,8- 4.1 x 10-8 3.9 x 10-10 2.0 X 10-10
0
2,3,6- 2.2 x 10-7 2,3,4,6,7,8- 4.7 x 10-8 6.9 X 10- 10 5.8 X 10-1
1,2,3,4,7,8- 2.8 x 10-7 2.1 X 10-9 4. 1 X 10-9 1 , 2,3,7,8- 7.5 x 10-8 2.5 X 10-9 3.1 X 10-8
1,3,7,8- 7.9 x 10-7 5.9 X 10-7 3.2 X 10-7 1 , 2,3 ,7- 1.1 x 10-7 2.7 X 10-5 6.3 X 10-5
1,2,4,7,8- 1.1 x 10-6 2.1 X 10-8 1.1 X 10-8 1 ,3 ,4,7,8- 2.0 x 10-7 1.6 X 10-9 1.4 X 10-9 ?S
ti
1 ,2,3,4- 1.3 x 10-6 3.7 X 10-6 2.4 X 10-6 2,3 ,4,7,9- 2.0 x 10-7 7.9 X 10-9 5.8 X 10-9 ti
X 10-7 1.4 2.0 10-7 4.1 X 10-8 3.8 X 10-8
'"
2,3,7- 7. 1 x 10-8 3.6 X 10-7 2,3 ,4,8- x
0 >
2,8- 3.2 x 10-6 >1.0 x 10 -4 >1.0 x 10-4 1 , 2,3,4,7,8- 2.3 x 10-7 3.6 X 10- 10 3.8 X 10-1 Z
1 ,2,3,4,7- 6.4 x 10-6 6.6 X 10-7 8.2 X 10-7 1 , 2,3,6,7,8- 2.7 x 10-7 1.5 X 10-9 1.2 X 10-9 ti
"0
1 , 2,4- 1.3 x 10 -5 4.8 x 10-5 2.2 X 10-6 1 , 2,3,7,9- 4.0 x 10-7 8.6 X 10-8 8.6 X 10-8 n
OCDD >1.0 x 10-5 3.1 X 10-7 7.0 X 10-7 1 , 2,4,7,8- 1.3 x 10-6 1.1 X 10-7 1.5 X 10-7 ti
:" >Tj
1- >1.0 x 10-4 >1.0 10-4 > 1.0 X 10-4 1 , 2 ,4,6,8- 3.1 10 6 1.0 10-5 1.2 X 10-5
1>
x x x
iI:'
'"
W
--.J
\0
380 SAFE
+++
-
I
Q-- -:- - OJ
9
-
I 1 +++
-
- <,'> -
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
Figure 2 The differential effects of chlorine substituents at different positions in the dibenzo-p
dioxin and dibenzofuran rings on the relative receptor binding affinities of PCDD and PCDF
congeners.
C-7). In both cases the C-3 (or C-7) substituted compounds were 6.5-8 times
more active than the corresponding C-2 (or C-8) isomers as competitive ligands
for the rat hepatic cytosolic receptor protein. A comparison of the relative
binding affinities of a series of C- l (or C-9) and C-4 (or C-6) isomer pairs
illustrates the higher binding activities of the isomer that retains the C-4 (or C-6)
substituent. For example the ECso values for the 2,3,4,7-, 2,3,4,7,8-,
2,3,4,7,9-, and 2,3,4,6,7,8-substituted PCDFs were 2.5 x 10-8 M, 1.5 X
10- 8 M, 2.0 X 10-7, and 4.7 x 10-8 M whereas the values for the correspond
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
ing C-l (or C-9) isomers (i.e. 1,2,3,7-TCDF, 1,2,3,7,8-, and 1,2,3,7,9-
PeCDF, and 1,2,3,6,7,8-HCDF) were 1.1 x 10-7 M, 7.5 X 10-8 M, 3.4 X
10-7 M, and 2.7 x 10-7 M, respectively.
Figure 3 illustrates an overlay of 2,3,7,8-TCDD and 2,3,4,7,8-PeCDF, the
two most active PCDD and PCDF ligands for the Ah receptor. The molecular
areas and volumes of the dibenzofuran and dibenzo-p-dioxin ring systems are
similar, but the spatial orientations of their substituents exhibit marked dif
ferences. The C-3 (or C-7) substituents occupy a position between the lateral
2,3 (or 7,8) groups in 2,3,7,8-TCDD and clearly occupy the dominant lateral
position in the dibenzofuran ring system. The spatial orientations of the C-4
(and C-6) and C-2 (and C-8) substituents are comparable and exhibit less
overlap with the lateral positions of 2,3,7,8-TCDD; the C- l (or C-9) PCDF
substituents exhibit the least overlap with the lateral positions of 2,3,7,8-
TCDD. These observations on the molecular orientations of the dibenzofuran
Cl substituents are consistent with the observed SARs for PCDF receptor
binding affinities and illustrate the stereospecific nature of the receptor protein
ligand interactions.
O-PCDD D-PCDF
Figure 3 Overlay of 2,3,7,8-TCDD and 2,3,4,7,8-PeCDF structures.
the receptor binding avidities of these compounds. For example the ECso value
for 7-trifluoromethyl-2,3-dichlorodibenzo-p-dioxin (1.95 X 10-8 M) was
1000 times lower than the value for 7-amino-2,3-dichlorodibenzo-p-dioxin
(2.88 x 10 5 M). The effects of different substituents on the activity of a series
-
X I()Y I()Y0 CI
O CI CI
CI CI
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
CI
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
X=CF3 , Br, I, CI, F, OH, CH3, X=H, OH, CH3, F, OCH3, COCH3, eN,
OCH3, N02, CN, NH2 ( )
CI, CH2CH3, Br, I, CH CH3 2' CF3
X CI X CI
O CI oyci
CI
Figure 4 Structures of substituted PCDDS, PCDFs, and polychlorinated biphenyls used for
QSAR studies.
w
00
-I'>
en
>
"T:I
7r S tIl
r 8
7
L;:
7r
t-C4Hg
0I i-C3H7
L;: 6
0 CsHs
:1
":.
I r<'l '0
0I
r<'l N
N I r<'l 41
I x t-C4Hg N
x I t-C4Hg
I 5 6 X 6
<XI
0
g U
10 0
10
u U
UJ UJ
UJ
0>
.34
I
.3
I
5
I
5
0 1 2 0 1 2
r -I 0 2
I
err-
1T 'if
Figure 5 Correlation between receptor binding avidities for the substituted PCDDs and PCDFs vs the substituent lipophilicity (1T) values_
PCDDs AND PCDFs-SARs 385
The bulky t-C4H9 and C6HS substituents were also treated as outliers for the
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
AHH INDUCTION ACTIVITIES OF PCDDs AND PCDFs The in vivo and in vitro
SARs for PCDDs and PCDFs as inducers of hepatic and extrahepatic AHH have
been reported by several groups (37, 38, 47-49, 51-53). The most active
PCDDs were substituted in their 2,3,7, and 8 position; inspection of the data in
Table 1 indicates that there were comparable SARs for PCDDs as ligands for
the receptor protein and as AHH inducers; however, there is not a linear
correlation between these two bioassays. SARs for several PCDF congeners as
in vitro AHH inducers were comparable to those already discussed for receptor
binding. Moreover, for the PCDFs summarized in Table 1 a comparison of in
vitro ECso values for AHH induction in rat hepatoma H-4-U E cells and in vivo
EDsos for AHH induction in male Wistar rats showed a linear correlation
between these two values. Like the PCDD congeners, however, there was not a
strong correlation between AHH induction potencies and receptor binding
avidities for the PCDF congeners. A comparison of the AHH and EROD
induction potencies of t 7-substituted-2,3-dichlorodibenzo-p-dioxins with
their rat hepatic cytosolic receptor binding avidities also showed that there was
not a linear correlation between the two in vitro activities for this series of
386 SAFE
Like the receptor binding avidities for these substituted PCDDs, their AHH
induction potencies were dependent on substituent lipophilicity; however, a
second parameter, STERIMOL (ABs) has also been included in the derivation
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
log ( l /ECso)AHH =
O .761T + 1 . 1 1 ABs + 2 . 23 O'p + 6 . 78 7.
Both Equations 5 and 6 showed that AHH induction potencies for the 8-
substituted-2,3-dichlorobenzofurans and 2,3-dichlorodibenzo-p-dioxins were
dependent on substituent and B5 p arameters . The correlation for the more
highly chlorinated set of analogs, the 8-substituted-2 , 3 ,4-trichlorodibenzo
furans, also includes a Hammett substituent parameter (O'p); presumably the
requirement for 0'p must be due to the effects of the C-4 chlorine group, which
constitutes the only structural difference between the two sets of substituted
PCDP analogs .
Equations 8-10 were developed from the AHH and EROD induction data for
the 8-substituted-2,3-dichlorodibenzo-p-dioxins, -2,3-dichlorodibenzofurans,
and -2,3,4-trichlorodibenzofurans , respectively .
The doseresponse acute toxicities of nine PCDD isomers and congeners in the
guinea pig and responsive mouse have been reported (33, 34, 126). The
relative LD50 values in both species were highly dependent on the number of
lateral CI substituents and the degree of substitution; their rank order of toxic
potencies was similar to their in vitro receptor binding and AHH induction
activities as discussed above. A comparative study (127) of the toxicity of
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
2,3,4,7,8- F2,3,7,8-TCOol
lOr
',2,3,4,7,8-....... I
'e-PCOF mix
2,3,4,6,7,8- ......
1,2,3,4, 7,8- = , 3,7,8-T COO
[!=2 I
e 10
9f- ___ 1,2.3,6,7,8" '\.
1,2,3,7,8-
PCDF mix .. e-2,3,4,7,8-
-.e
_
_ 2,3,7,8-
e_2,3,4,6,7,8-
_-2,3,4,7,9- 9 1,2,3,6,7,8--e
U
:5 8 1 e-1,3,4,7,8-
e
e-1,2,3,6,7,8-
2,3,7,8- -e-2,3.4,7,9-
lIJ
1,2,3,7,9-_e 8
F 7 .-1,2,4,7,8- e - 1,3,4,7,8-
.!.
U
'C lIJ
,7,9 -
go 7 1,2,4,7. 8- _1-1,2,3
:J: 6 I
:J:
-0
6
5f-
:J:
go
:J:
5 '"
-'---
o
2 3 4 5 6 7 8
Body WI. Loss Hog ED501 ?5
2 3 4 5 6 7 8 Sil
Thymic Atrophy HogED501
1>
Figure 6 A plot of the -log ECso values for in vitro AHH induction vs the -log EDso values for thymic atrophy (right) and body weight loss (left) in the male :;:Q
'"
Wistar rat for several PCDF congeners and 2,3,7,8-TCDD,
\;J
00
\0
390 SAFE
genetics except for one allele at the hr locus. Topical application of 2,3,7,8-
TCDD to the dorsal skin of hairless mice resulted in epidermal hyperplasia,
sebaceous gland metaplsia, and hyperkeratosis, but these histological lesions
are not observed in hrl+ haired mice. The development of a graded epidermal
response by several PCDD congeners, 2,3,7,8-TCDF, and related toxic aryl
hydrocarbons was structure-dependent and correlated with rank order of recep
tor binding affinities for these compounds ( 1 28) . For example, the total dose
(nmol/mouse) required to produce a 2+ response was 0.36, 1 .76, 1 .2 > 360 and
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
Genetic Evidence
Pharmacogenetic studies with genetically inbred strains of mice typefied by the
Ah-responsive C57BLl6 and nonresponsive DBA/2 mice have provided strong
evidence in support of the role of the Ah receptor in mediating the biologic and
toxic effects of toxic halogenated aryl hydrocarbons. Nonresponsive DBA/2
mice contain relatively low levels of hepatic or extrahepatic cytosolic or nuclear
Ah receptor 1 fmoVmg cytosolic protein) , whereas much higher levels of the
receptor are detected in responsive strains of mice. The EDso for 2,3,7,8-
TCDD mediated hepatic microsomal AHH induction in C57B 1/6J mice was 1
nmol/kg whereas this value is at least tenfold higher in DBAl2J mice. In genetic
crosses and backcrosses between C57BLl6J and DBA/2J mice the trait or
responsiveness to AHH induction is inherited in a simple autosomal mode (50,
1 32-1 34). The responsive backcross animals also had detectable hepatic recep
tor levels (85 , 89, 97 , 1 03 , 1 09). The segregation of the toxicity of PCDDs and
PCDFs with the Ah locus has been determined primarily with 2,3,7,8-TCDD
using both responsive and nonresponsive genetically inbred mice and their
PCDDs AND PCDFs-SARs 391
crosses and backcrosses. The results illustrate that several toxic effects includ
ing teratogenicity, porphyria and hepatotoxicity, immunotoxicity, and body
weight loss segregate with the Ah locus (75-80, 1 35-1 39) . Dermal toxic
lesions appear to be dependent on the interaction between the Ah and hr locus as
previously noted ( 1 28-1 30). It has also been suggested that additional genetic
loci may also be involved in the hepatotoxic effects of 2,3 ,7,8-TCDD, however
this observation requires further substantiation ( 1 40).
by Stanford University - Main Campus - Lane Medical Library on 03/30/13. For personal use only.
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
Although the SARs and toxicology of PCDDs and PCDFs have been ex
tensively studied the interactive effects of PCDD/PCDF mixtures and related
compounds are not well understood. 2,3,7 ,8-TCDD can act as a tumor promot
er for several initiators in the rodent liver ( 4 1 ) , mouse skin ( 30), and
C3H/lOTII2 cells ( 142), and as a cocarcinogen causing 3-methylcholanthrene
initiated subcutaneous tumors in nonresponsive DBA/2 mice ( 1 43). In contrast,
2 , 3 ,7 , 8-TCDD exhibits anticarcinogen activity in female CD- l mice ( 1 44) .
These effects are related to the agent's induction of drug-metabolizing enzymes
that alter rates of metabolic activation of polynuclear aromatic hydrocarbon
initiators. Several studies (5 1 , 5 3 , 1 20, 145 , 146) report the application of in
vitro bioassays as short-term tests for assessing the potential toxicity of PCDD/
PCDF mixtures; a comparison of the in vitro AHH induction activity of a
reconstituted mixture of PCDFs identified in Yusho patients ( 147) and the
toxicity of this mixture (Figure 6) suggest that the effects of the individual
PCDFs in this mixture are additive ( 148) . In contrast, the immunotoxicity and
AHH induction activity of 2 , 3 ,7 , 8-TCDD in C57BL/6 mice were decreased by
coadministering a nontoxic or noninducing dose of 2,3 ,7 ,8-TCDF 00 j.Lg/kg)
( 149). A rational explanation for the antagonistic effects of 2,3,7,8-TCDF is
not apparent.
Birnbaum and co-workers (77) have reported that treatment of pregnant mice
with a combination of 2 , 3 , 7 ,8-TCDD (3 j.Lg/kg) and a nontoxic dose of
2 , 3 ,3' ,4,4' ,5-hexachlorobiphenyl (20 j.Lg/kg) resulted in a tenfold increase in
incidence in cleft palate compared to those animals receiving only 2 , 3 ,7 , 8-
TCDD. A second PCB congener, 2,2' ,4,4' ,5,5' -hexachlorobiphenyl , at dose
levels of 50 or 25 mg/kg in combination with 2 , 3 ,7 ,8-TCDD (3 j.Lg/kg), did not
effect the teratogenic potency of the latter compound. Although 2,3,3' ,4,4' ,5-
hexachlorbiphenyl is less toxic than 2 , 3 ,7,8-TCDD, this monortho coplanar
PCB congener elicits several receptor-mediated biologic and toxic effects (74).
It is conceivable that the interactive effects of 2 , 3 , 3 ' ,4,4' ,5-hexachlorobi
phenyl and 2 , 3 , 7 ,8-TCDD may be additive if the dose-response curve for
the former compound is steep and if the 20 mg/kg dose level is just
392 SAFE
probes for delineating the mechanism of action of PCDDs and PCDFs and the
role of the receptor protein in mediating these effects. These interactive studies
will also be_ important for assessing the effects of polyhalogenated aromatic
environmental pollutant mixtures and their potential human health impact.
ACKNOWLEDGMENTS
Literature Cited
54. Goldstein, J. A . , Linko, P. 1984. Differ 64. Beatty , P. W., Neal, R. A. 1976. Induc
ential induction of 2,3, 7 ,8-tetrachlorodi tion of DT-diaphorase by 2,3, 7,8-
benzo-p-dioxin-inducible fonns of cy tetrachlorodibenzo-p-dioxin (TCDD).
tochrome P-450 in extrahepatic versus Biochem. Biophys. Res. Commun.
hepatic tissues. Mol. Pharmacol. 25: 68: 197-204
185-91 65. Nebert, D. W., Jensen, N . , Perry, J . ,
55. Tukey, R . H., Negishi, M . , Nebert, D. Oka, T . 1980. Associations between
W. 1982. Quantitation of hepatic cyto ornithine decarboxylase E,C.-4. 1 . 1 . 17
chrome P,-450 mRNA with the use of induction and the Ah locus in mice
cloned DNA probe: effects of various P- treated with polycyclic aromatic com
450 inducers in C57BLl6N and DBA/2N pounds. 1. Bioi. Chem. 255:6836-
mice. Mol. Pharmacol. 22:779-86 42
56. Tukey, R. H. , Nebert, D. W. 1984. 66. Puhvel, S. M . , Ertl , D. C . , Lynberg, C.
Regulation of mouse cytochrome P3-450 A. 1984. Increased epidennal transgluta
by the Ah receptor studies with P3"450 minase activity following 2 ,3,7,8-tetra
DNA clone. Biochem. 23:6003-8 chlorodibenzo-p-dioxin: In vivo and in
57. Kimura, S . , Gonzalez, F. J . , Nebert, D. vitro studies in mouse skin. Toxicol.
W. 1984. The murine Ah locus. Com Appl. Pharmacol . 73:42-47
parison of the complete cytochrome PI- 67. Kurl, R. N . , Lund, J . , Poellinger, L. ,
450 and P3"450 DNA nucleotide and ami Gustafsson, J-A. 1982. Differential ef
no acid sequences. 1. Bioi. Chem. fects of 2,3,7 ,8-tetrachlorodibenzo-p
259: 1 0705- 13 dioxin on nuclear RNA polymerase activ
58. Thomas, P. E., Reedy, J., Reik, L. M . , ity in the rat liver and thymus. Biochem.
Ryan, D. E . , Koop, D. R . , Levin, W . Phannacol. 3 1 :2459-62
1984. Vse of monoclonal antibodies 68. Sawahata, T . , Olson, J. R . , Neal, R . A .
probes against rat hepatic cytochromes 1982. Identification of metabolites of
P-450c and P-450d to detected im 2,3,7,8-tetrachlorodibenzo-p-dioxin
munochemically related isozymes in liv (TCDD) fonned on incubation with iso
er microsomes from different species. lated rat hepatocytes. Biochem. Biophys.
Arch. Biochem. Biophys . 235:239- Res. Commun. 105:34 1-46
53 69. Poland, A . , Glover, E. 1979. An es
5 9 . Serabjit-Singh, C. J . , Albro, P. W . , timate of the maximum in vivo covalent
Robertson, I. G. C . , Philpot, R . M. binding of 2,3,7 ,8-tetrachlorodibenzo-p
1983. Interaction between xenobiotics dioxin to rat liver protein, ribosomal
that increase or decrease the levels of RNA and DNA. Cancer Res. 39:3341-
cytochrome P-450 isozymes in rabbit 44
lung and liver. J. Bioi. Chem. 258: 70. Weber, H . , Poiger, H . , Schlatter, C .
12827-34 1982. Fate of 2,3,7,8-tetrachlorodiben
60. Liem, H. H., Muller-Eberhard, V . , zo-p-dioxin metabolites from dogs and
Johnson , E. F . 1980. Differential induc rats . Xenobiatica 12:353-57
tion of 2,3,7 ,8-tetrachlorodibenzo-p 71. Weber, H . , Poiger, H . , Schlatter , C .
dioxin of multiple-fonns of rabbit micro 1982. Acute oral toxicity o f TCDD
somal cytochrome P-450: evidence or metabolites in male guinea pigs. Toxicol.
tissue specificity . Mol. Pharmacol. 18: Lett . 14: 177-82
565-70 72. Rozman, K . , Rozman , T . , Greim. H .
6 1 . Baars, A. J . , Jansen, M . , Breimer, D. D . 1984. Effect o f thyroidectomy and thy- .
1978. The influence o f phenobarbital, 3 - roxine on 2,3 ,7,8-tetrachlorodibenzo-p
methylcholanthrene and 2,3,7 ,8-tetra dioxin (TCDD) induced toxicity. Tox
chlorodibenzo-p-dioxin on glutathione S icol. Appl. Pharmacol. 72:372-76
transferase activity of rat liver cytosol. 73. pazdernik, T. L . , Rozman, K. L. Effect
Biochem. Pharmacal. 27:2487-94 of thyroidectomy and thyroxine on
396 SAFE
tetrachlorodibenzo-p-dioxin to the Ah re
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org
ceptor in extrahepatic tissues of rats and its endocrine independence. Cancer Res.
mice. Eur. J. Biochem. 123:209-- 1 5 39:4653--5 6
9 7 . Okey, A. B . , Mason, M. E . , Vella, L . 107. Poellinger, L . , Lund, J., Gillner, M . ,
M . 1983. The A h receptor: species and Hansson, L. A . , Gustaffson, J. A. 1984.
tissue variation in binding of 2,3,7,B Physiochemical characterization of spe
tetrachlorodibenzo-p-dioxin and carcino cific and nonspecific polyaromatic
genic aromatic hydrocarbons. In Ex hydrocarbon binders in rat and mouse
trahepatic Drug Metabolism and Chemi liver cytosol. J. Bioi. Chem. 258: 1 3535-
cal Carcinogenesis, ed. J. Rydstrom, M. 42
Bengtsson, pp. 389--93. Amsterdam: 108. Okey, A. B . , Vella, L. M . , Iverson, F.
Elsevier 1984. Ah receptor in primate liver: bind
98. Miller, A. G . , Israel, D . , Whitlock, J. P. ing of 2,3,7 ,8-tetrachlorodibenzo-p
1983. Biochemical and genetic analysis dioxin and carcinogenic polycyclic
of variant mouse hepatoma cells de aromatic hydrocarbons. Can. J. Physial.
fective in the induction of benzo[a] Pharmacal. 62: 1292-95
pyrene metabolizing enzyme activity. 109. Nebert, D. W . , Eisen, H. J . , Hankinson,
J. Bioi . Chem. 258:3523-27 O. 1984. The Ah receptor: binding
99. Okey, A. B . , Bondy, G. P. , Mason, M. specificity only for foreign chemicals.
E . , Nebert, D. W . , Forster-Gibson, C. Biachem. Pharmacal. 33:917-24
J., et al. 1980. Temperature-dependent 1 1 0. Hudson, L. G . , Shaikh, R . , Toscano, W.
cytosol-to-nucleus translocation of the A., Greenlee, W. F. 1983. Induction of
Ah receptor for 2,3,7,8-tetrachlorodi 7 -ethoxycoumarin O-deethylase activity
benzo-p-dioxin in continuous cell culture in - '.lltured human epithelial cells by
lines. J. Bioi. Chem. 255 : 1 1415--22 ,,:,3,7,8 - tetrachlorodibenzo - p - dioxin
100. Carlstedt-Duke, J. M. B . , Harnemu, U. (TCDD): evidence for a TCDD receptor.
B . , Hogbert, B . , Gustafsson, J. A. 19B I . Biochem. Biaphys. Res. Cammun . 1 15:
Interaction of hepatic receptor protein for 6 1 1-17
2,3,7,8-tetrachlorodibenzo-p-dioxin I l l . Jones, P. B . C., Miller, A. G., Israel, D.
with DNA. Biochem. Biophys. Acta I . , Galeazzi , D. R., Whitlock, J. P.
672: 1 3 1--41 1984. Biochemical and genetic analysis
101. Whitlock, J . P . , Galeazzi, R. 1984. of variant mouse hepatoma cells which
2 , 3 ,7,8-Tetrachlorodibenzo-p-dioxin re overtranscribe the cytochrome P ,-450
ceptors in wild type and variant mouse gene in response to 2,3,7,8-tetrachloro
hepatoma cells; nuclear location and dibenzo-p-dioxin. J. Bioi. Chem. 259:
strength of nuclear binding. J. Bioi. 12357-63
Chem. 259:980--85 1 1 2. Israel, D. I . , Whitlock, J. P. 1984. Regu
102. Poellinger, L . , Kurl, R. N . , Lund, J . , lation of cytochrome P,-450 gene
Gillner, M. , Carlstedt-Duke, J. M. B . , et transcription by 2,3,7,8-tetrachlorodi
al. 1982. High affinity binding of benzo-p-dioxin in wild type and variant
2,3, 7 ,8tetrachlorodibenzo-p-dioxin in mouse hepatoma cells. J. Bioi. Chem.
cell nuclei from rat liver. Biochem. Bio 254:5400--2
phys. Acta 7 14:5 16--23 1 1 3. Jones, P. B . C . , Galeazzi, D. R . , Fisher,
1 03 . Gasiewicz, T. A. and Rucci, G. 1984. J. M . , Whitlock, 1. P. 1985. The control
Cytosolic receptor for 2,3,7,8-tetrachlo of cytochrome P ,-450 gene expression by
rodibenzo-p-dioxin. Mol. Pharmacal. dioxin. Science 227: 1499--1 502
26:90--98 1 14. Ringold, G. M. 1985. Steroid hormone
104. Gasiewicz, T. A . , Ness, W. C . , Rucci, regulation of gene expression. Ann. Rev.
G. 1984. Ontogeny of the cytosolic re Pharmacal. Taxical. 25:529-66
ceptor for 2,3,7 ,8-tetrachlorodibenzo-p 1 15. Safe, S . , Safe, L. 1984. Synthesis and
dioxin in rat liver, lung and thymus. characterization of twenty-two poly-
398 SAFE
1 39. Vecchi , A., Mantovani , A., Sironi, M . , bons. Cancer Res. 40:1 580-87
Annu. Rev. Pharmacol. Toxicol. 1986.26:371-399. Downloaded from www.annualreviews.org